News

Technology News

RareCyte Readies Detection Platform For Launch

Wednesday, August 22, 2012 5:14:00 AM PDT | VentureDeal
   Seattle, Washington  --  Life science company RareCyte has closed the second tranche of a recent funding round.

RareCyte is in the final stages of developing a platform designed to target circulating tumor and endothelial cells for analysis.

The company said it would use the funding to complete product development and initiate commercial launch into the research oncology market.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.